marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-14-2023
Navidea Biopharmaceuticals Cash Flow 2011-2024 | NAVB
Annual Cash Flow Navidea Biopharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-8.99 M | -10.2 M | -8.17 M | -9.35 M | 4.28 M | 59.1 M | 3.56 M | -19.1 M | -29.1 M | -35.6 M | -23.9 M | -16 M |
Depreciation & Amortization |
48.2 K | 36.8 K | 33.9 K | 103 K | 121 K | 232 K | 496 K | 562 K | 488 K | 400 K | 199 K | 175 K |
Accounts Payables |
2.12 M | 1.42 M | 1.16 M | 1.11 M | 425 K | 855 K | 5.17 M | 1.77 M | 1.48 M | 2.42 M | 1.42 M | 682 K |
Accounts Receivables |
630 | 93 K | 2.99 M | 901 K | 21.2 K | 8.14 M | 203 K | 3.7 M | - | 1.15 M | 17.6 K | - |
Total Inventories |
427 K | 151 K | 170 K | - | - | - | 96.2 K | 653 K | 932 K | 2.23 M | 298 K | 822 K |
All numbers in USD currency
Quarterly Cash Flow Navidea Biopharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -1.72 M | - | -6.55 M | -4.7 M | -2.56 M | - | -7.49 M | -5.48 M | -3.06 M | - | -5.62 M | -2.99 M | -951 K | - | -6.62 M | -4.28 M | -2.17 M | - | 6.4 M | 8.29 M | -2.26 M | - | 61 M | 62 M | 67.7 M | - | 1.3 M | -1.36 M | - | - | - | - | -4.11 M | - | - | -17.6 M | -9.17 M | - | -24.5 M | -14.8 M | -7.4 M | - | -16.6 M | -11.5 M | -6.59 M | - | -6.3 M | -2.59 M | -1.79 M |
Depreciation & Amortization |
27 K | 27.1 K | 27.6 K | - | 24.7 K | 21.8 K | 22.9 K | - | 55.7 K | 37.6 K | 17.7 K | - | 51.5 K | 36.1 K | 16.8 K | - | 108 K | 73.5 K | 36.8 K | - | 113 K | 75.5 K | 38 K | - | 212 K | 162 K | 86.5 K | - | 379 K | 267 K | 150 K | - | 132 K | 149 K | 150 K | - | 361 K | 235 K | 111 K | - | 320 K | 235 K | 76.1 K | - | 139 K | 87.1 K | 33.9 K | - | 151 K | 110 K | 59.6 K |
Accounts Payables |
- | 2.01 M | 3.17 M | 2.12 M | 1.74 M | 2.43 M | 1.56 M | 1.42 M | 1.21 M | 1.08 M | 1.23 M | 1.16 M | 1.16 M | 1.16 M | 1.16 M | 1.11 M | 1.11 M | 1.11 M | 1.11 M | 425 K | 425 K | 425 K | 425 K | 855 K | 855 K | 855 K | 855 K | 5.17 M | 5.17 M | 5.17 M | 5.17 M | 1.53 M | 1.77 M | 1.77 M | 1.77 M | 1.48 M | 1.48 M | 1.48 M | 1.48 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 1.42 M | 1.42 M | 1.42 M | 1.42 M | 682 K | 682 K | 682 K | 682 K |
Accounts Receivables |
- | - | - | - | - | - | - | 93 K | - | - | - | 2.99 M | - | - | 1.7 M | 901 K | 146 K | 207 K | 901 K | 21.2 K | 21.2 K | 21.2 K | 21.2 K | 8.14 M | 8.14 M | 8.14 M | 8.14 M | 203 K | 203 K | 203 K | 203 K | 10.4 K | 1.91 M | 1.83 M | 1.21 M | 817 K | 1.47 M | 817 K | 817 K | 1.15 M | 158 K | 1.15 M | 1.15 M | 17.6 K | 22.8 K | 17.6 K | 17.6 K | 15.8 K | 15.8 K | 2.03 M | - |
Total Inventories |
461 K | 461 K | 461 K | 427 K | 194 K | 316 K | 323 K | 151 K | 179 K | 179 K | 166 K | 170 K | 170 K | 170 K | 170 K | - | - | - | - | - | - | - | - | - | - | - | 748 | 96.2 K | 96.2 K | 96.2 K | 96.2 K | 653 K | 653 K | 653 K | 653 K | 932 K | 932 K | 932 K | 932 K | 2.23 M | 2.23 M | 2.23 M | 2.23 M | 298 K | 298 K | 298 K | 298 K | 822 K | 822 K | 822 K | 822 K |
All numbers in USD currency